semaglutide and rosuvastatin Evaluating the Cardiovascular Benefits of Innovator 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence 1 receptor agonists (glucagon Media Centre | EASD

The company designs peptide analogs to enhance biological activity, extend duration of action, and increase stability, thereby providing innovative and improved treatments for various diseases

[8] Li F, Cui L, Yu D, Hao H, Liu Y, Zhao X, et al

Without a licensed SmPC, there is no authoritative basis on which to specify how retatrutide should be reconstituted

It will come in two doses: 0.5 and 1.0 mg once weekly

Common Side Effects (Both) Nausea (typically improves after 2-4 weeks) Diarrhea or constipation Decreased appetite (this is the goal) Mild stomach discomfort Fatigue during dose titration Injection site reactions (rare) Key Differences Nausea rates: Similar between both (~15-25%), though some patients tolerate one better than the other GI side effects: Generally comparable